| Symbol | INBS |
|---|---|
| Name | INTELLIGENT BIO SOLUTIONS INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | New York, 10019, United States |
| Telephone | +1 646 828-8258 |
| Fax | — |
| — | |
| Website | https://www.ibs.inc |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001725430 |
| Description | Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. Additionally, the Companys biosensor platform has the potential to test for up to 130 indications, ranging from glucose to immunological conditions and communicable diseases. Additional info from NASDAQ: |
New Form SCHEDULE 13G - INTELLIGENT BIO SOLUTIONS INC. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001172661-26-002160 <b>Size:</b> 10 KB
Read moreIntelligent Bio Solutions Inc. - Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
Read moreIntelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
Read moreIntelligent Bio Solutions Inc. - Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
Read moreIntelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
Read moreIntelligent Bio Solutions Inc. - Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
Read moreIntelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
Read moreIntelligent Bio Solutions Inc. - Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market
Read moreIntelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market
Read moreIntelligent Bio Solutions Inc. - Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07580365 | VirtualPark_Pediatric | Na | Dystrophinopathy | Not_Yet_Recruiting | 2026-06-01 | 2028-06-01 | ClinicalTrials.gov |
| NCT07430670 | Theravex Oral and Theravex Tissue Care Plus in the Healing Process of Mucogingi… | Na | Gingival Recession, Localized | Recruiting | 2026-02-17 | 2027-07-06 | ClinicalTrials.gov |
| NCT07092436 | Pediatric Upper-Limb Rehabilitation With PhiCube, a Modular Bilateral End-Effec… | Na | Congenital and Acquired Neuromotor Disorders | Recruiting | 2025-11-17 | 2026-11-01 | ClinicalTrials.gov |
| NCT07132151 | Reinforcement Learned Automated Anesthesia Systems During Painless Abortion | Na | Painless Abortion | Not_Yet_Recruiting | 2025-09-08 | 2027-11-08 | ClinicalTrials.gov |
| NCT06963606 | Effectiveness of Computer-Aided Detection Chest X-Ray Screening for Improving T… | Na | Tuberculosis (TB) | Recruiting | 2025-09-01 | 2027-12-31 | ClinicalTrials.gov |
| NCT07050654 | Motivation While Doing Physical Exercise in a Social Dual-task Virtual Environm… | Na | Healthy Volunteer | Completed | 2025-09-01 | 2025-12-18 | ClinicalTrials.gov |
| NCT07096583 | An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression … | Phase1 | Ovary Cancer | Active_Not_Recruiting | 2025-07-07 | 2027-07-30 | ClinicalTrials.gov |
| NCT07032155 | Virtual Reality in Occupational Therapy Upper Limb Stroke Rehabilitation | Na | Stroke | Not_Yet_Recruiting | 2025-07-01 | 2025-12-31 | ClinicalTrials.gov |
| NCT06963333 | Clinical Study on Improving Exercise Capacity in Chronic Obstructive Pulmonary … | Na | Chronic Obstructive Pulmonary Disease | Not_Yet_Recruiting | 2025-06-15 | 2028-07-31 | ClinicalTrials.gov |
| NCT06857344 | Reinforcement Learned Automatic Anesthesia System During Painless Gastrointesti… | Na | Anesthesia Induction | Recruiting | 2025-05-01 | 2025-10-01 | ClinicalTrials.gov |
| NCT06813703 | Analysis of the Analgesic Mechanism of TENS-WAA During Non-anesthetized Colonos… | Na | Colonoscopy | Recruiting | 2025-02-18 | 2026-02-15 | ClinicalTrials.gov |
| NCT07580599 | Enhanced Early Soft-Tissue Healing With THERAVEX Technology | Na | Wound Healing Time | Completed | 2024-12-03 | 2026-01-01 | ClinicalTrials.gov |
| NCT07564843 | Theravex® for Burning Mouth Syndrome | Na | Primary Burning Mouth Syndrome (BMS) | Completed | 2024-10-06 | 2025-09-01 | ClinicalTrials.gov |
| NCT06550349 | ScanNav Anatomy PNB Data Collection Study 2024 | — | Data Collection | Completed | 2024-08-27 | 2024-08-28 | ClinicalTrials.gov |
| NCT06618183 | Drug Screening System Method Comparison | — | Reagent Kits, Diagnostic | Recruiting | 2024-08-26 | 2024-12-31 | ClinicalTrials.gov |
| NCT06423547 | Risk Warning Model of Postoperative Delirium and Long-term Cognitive Dysfunctio… | — | Postoperative Delirium | Recruiting | 2024-07-30 | 2027-12-31 | ClinicalTrials.gov |
| NCT06519045 | PK of Codeine and Metabolites in Human Fingerprint Sweat, Oral Fluid, Blood and… | — | Pharmacokinetics | Active_Not_Recruiting | 2024-06-11 | 2024-09-30 | ClinicalTrials.gov |
| NCT06344494 | Cardiac Interventional ICE Imaging Trial | Na | Structural Heart Diseases | Not_Yet_Recruiting | 2024-05-01 | 2026-05-01 | ClinicalTrials.gov |
| NCT06032572 | Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) | Na | Coronary Artery Disease | Unknown | 2023-09-08 | 2024-08-01 | ClinicalTrials.gov |
| NCT05952050 | Different Administration Routes of Dexmedetomidine on Postoperative Delirium | Na | Dexmedetomidine | Unknown | 2023-08-01 | 2023-09-30 | ClinicalTrials.gov |
| NCT05963243 | Automated Dating Scan Probe Pressure Data Collection Plan | — | Ultrasound | Completed | 2023-08-01 | 2024-01-12 | ClinicalTrials.gov |
| NCT05945004 | ChatGPT v.s. Human in Writing a Preoperative Visit Sheet | — | Preoperative Care | Unknown | 2023-08-01 | 2023-09-01 | ClinicalTrials.gov |
| NCT05963230 | ScanNav Anatomy PNB FDA Data Collection Plan | — | Ultrasound Recordings | Completed | 2023-07-01 | 2023-07-21 | ClinicalTrials.gov |
| NCT05676788 | HSI for Intersegmental Plane Identification During Sublobar Pulmonary Resections | Na | Lung Neoplasm | Not_Yet_Recruiting | 2023-04-01 | 2027-06-01 | ClinicalTrials.gov |
| NCT05992805 | ScanNav Anatomy PNB Data Collection Study | — | Data Collection | Completed | 2023-03-22 | 2023-05-12 | ClinicalTrials.gov |
| NCT05583032 | An Evaluation of the Long-Term Impact of Assistive AI on Anaesthetists' Ultraso… | — | Ultrasound Imaging of Anatomical Structures | Completed | 2022-11-24 | 2023-07-30 | ClinicalTrials.gov |
| NCT05411406 | Prediction of Difficult Mask Ventilation Using 3D-Facescan and Machine Learning | — | Mask Ventilation | Completed | 2022-11-07 | 2023-05-15 | ClinicalTrials.gov |
| NCT05593120 | Evaluation of Health Economics for Noninvasive Coronary Fractional Flow Reserve… | — | Coronary Artery Disease | Unknown | 2022-06-29 | 2022-12-30 | ClinicalTrials.gov |
| NCT05156099 | Clinical Performance Study: Evaluate Scanning & Interpretation Performance With… | — | Ultrasound Imaging of Anatomical Structures | Completed | 2021-12-06 | 2022-12-08 | ClinicalTrials.gov |
| NCT05210010 | A Prospective Study to Assess the Utility of CA-4F in a Canadian Cardiology Set… | Na | Transthyretin Amyloid Cardiomyopathy ("ATTR-CM") | Unknown | 2021-11-01 | 2022-05-31 | ClinicalTrials.gov |
| NCT04918693 | A Study to Evaluate the Performance and Potential Benefits of an Assistive Arti… | — | Ultrasound Imaging of Anatomical Structures | Completed | 2021-05-16 | 2021-11-30 | ClinicalTrials.gov |
| NCT04906018 | A Study to Collect Imaging Data for the Validation of the Intelligent Ultrasoun… | — | Ultrasound Imaging of Anatomical Structures | Completed | 2021-05-16 | 2021-11-30 | ClinicalTrials.gov |
| NCT06371430 | Bone Bioactive Liquid Efficiency in Improving Dental Implant Osteointegration O… | Na | Wound Healing Disorder | Completed | 2021-04-14 | 2024-04-14 | ClinicalTrials.gov |
| NCT04830891 | A Volunteer Study to Collect Imaging Data for the Development and Validation of… | — | Ultrasound Imaging of Anatomical Structures | Completed | 2021-02-08 | 2022-04-22 | ClinicalTrials.gov |
| NCT04749524 | Otoacoustic Emission Suppression Study | — | Neonatal Hearing Loss | Completed | 2020-04-01 | 2023-07-12 | ClinicalTrials.gov |
| NCT03971578 | Screening for Autism Spectrum Disorders Using Auditory Brainstem Responses | — | Autism Spectrum Disorder | Completed | 2020-02-01 | 2022-07-31 | ClinicalTrials.gov |
| NCT04277169 | A Volunteer Study to Collect Imaging Data for the Development of the Intelligen… | — | Ultrasound Imaging of Anatomical Structures | Completed | 2020-02-01 | 2020-09-01 | ClinicalTrials.gov |
| NCT04040179 | A Volunteer Study to Collect Imaging Data for the Development of the ntelligent… | — | Ultrasound Imaging of Anatomical Structures | Completed | 2019-08-05 | 2019-09-30 | ClinicalTrials.gov |
| NCT03069768 | Stage Ib Trial of mSMART With Varenicline | Phase1 | Nicotine Dependence | Withdrawn | 2018-04-01 | 2019-06-01 | ClinicalTrials.gov |
| NCT03165175 | Mobile Application for Prescription Drug-Abuse Education (MAPDE) | Na | Prescription Drug Abuse (Not Dependent) | Completed | 2017-05-22 | 2018-10-17 | ClinicalTrials.gov |
| NCT03080597 | PrEP for HBCUs (Study 2) | Na | At Risk for HIV | Completed | 2017-03-01 | 2018-10-01 | ClinicalTrials.gov |
| NCT02895893 | PrEP SMART Phase I Trial | Phase1 | At Risk for HIV | Completed | 2016-07-01 | 2017-05-04 | ClinicalTrials.gov |
| NCT02635919 | Stage Ib Trial of mSMART for Smoking Cessation Medication Adherence | Na | Nicotine Dependence | Unknown | 2016-04-01 | 2018-11-01 | ClinicalTrials.gov |
| NCT05169333 | The Oxford Risk Factors And Non-Invasive Imaging Study | — | Cardiovascular Diseases | Recruiting | 2016-02-23 | 2030-02-01 | ClinicalTrials.gov |
| NCT02072005 | Mobile App Based Personalized Solutions and Tools for Medication Adherence of R… | — | Cigarette Smoking | Completed | 2014-02-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01124903 | Human Hydration Status Monitoring | Na | Dehydration | Completed | 2009-01-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00427180 | IRIS PILOT - Extended Pilot Study With a Retinal Implant System | Na | Retinitis Pigmentosa | Unknown | 2006-12-01 | 2010-12-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Warm saline | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| Chlorhexidine 0.12% (Paroex) | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| THERAVEX Total Oral Care Plus | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| Standard therapy | Drug | Approved | Dystrophinopathy | NOT_YET_RECRUITING | NCT07580365 |
| Dual-task cycling | Other | Approved | Dystrophinopathy | NOT_YET_RECRUITING | NCT07580365 |
| Warm saline | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| Chlorhexidine 0.12% (Paroex) | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| THERAVEX Total Oral Care Plus | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| Standard therapy | Drug | Approved | Dystrophinopathy | NOT_YET_RECRUITING | NCT07580365 |
| Dual-task cycling | Other | Approved | Dystrophinopathy | NOT_YET_RECRUITING | NCT07580365 |
| Warm saline | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| Chlorhexidine 0.12% (Paroex) | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| THERAVEX Total Oral Care Plus | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| Standard therapy | Drug | Approved | Dystrophinopathy | NOT_YET_RECRUITING | NCT07580365 |
| Dual-task cycling | Other | Approved | Dystrophinopathy | NOT_YET_RECRUITING | NCT07580365 |
| Warm saline | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| Chlorhexidine 0.12% (Paroex) | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| THERAVEX Total Oral Care Plus | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| Standard therapy | Drug | Approved | Dystrophinopathy | NOT_YET_RECRUITING | NCT07580365 |
| Dual-task cycling | Other | Approved | Dystrophinopathy | NOT_YET_RECRUITING | NCT07580365 |
| Warm saline | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| Chlorhexidine 0.12% (Paroex) | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| THERAVEX Total Oral Care Plus | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| Standard therapy | Drug | Approved | Dystrophinopathy | NOT_YET_RECRUITING | NCT07580365 |
| Dual-task cycling | Other | Approved | Dystrophinopathy | NOT_YET_RECRUITING | NCT07580365 |
| Warm saline | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| Chlorhexidine 0.12% (Paroex) | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| THERAVEX Total Oral Care Plus | Other | Approved | Wound Healing Time | COMPLETED | NCT07580599 |
| Standard therapy | Drug | Approved | Dystrophinopathy | NOT_YET_RECRUITING | NCT07580365 |
| Dual-task cycling | Other | Approved | Dystrophinopathy | NOT_YET_RECRUITING | NCT07580365 |
| THERAVEX® Total Oral Care Plus | Other | Approved | Primary Burning Mouth Syndrome (BMS) | COMPLETED | NCT07564843 |
| THERAVEX® Total Oral Care Plus | Other | Approved | Primary Burning Mouth Syndrome (BMS) | COMPLETED | NCT07564843 |
| THERAVEX® Total Oral Care Plus | Other | Approved | Primary Burning Mouth Syndrome (BMS) | COMPLETED | NCT07564843 |
| THERAVEX® Total Oral Care Plus | Other | Approved | Primary Burning Mouth Syndrome (BMS) | COMPLETED | NCT07564843 |
| THERAVEX® Total Oral Care Plus | Other | Approved | Primary Burning Mouth Syndrome (BMS) | COMPLETED | NCT07564843 |
| THERAVEX® Total Oral Care Plus | Other | Approved | Primary Burning Mouth Syndrome (BMS) | COMPLETED | NCT07564843 |
| THERAVEX® Total Oral Care Plus | Other | Approved | Primary Burning Mouth Syndrome (BMS) | COMPLETED | NCT07564843 |
| THERAVEX® Total Oral Care Plus | Other | Approved | Primary Burning Mouth Syndrome (BMS) | COMPLETED | NCT07564843 |
| CA-4F | Other | Approved | Transthyretin Amyloid Cardiomyopathy ("ATTR-CM") | UNKNOWN | NCT05210010 |
| CA-4F | Other | Approved | Transthyretin Amyloid Cardiomyopathy ("ATTR-CM") | UNKNOWN | NCT05210010 |
| Routine care | Other | Preclinical | Coronary Artery Disease | UNKNOWN | NCT05593120 |
| CT-FFR | Other | Preclinical | Coronary Artery Disease | UNKNOWN | NCT05593120 |
| Routine care | Other | Preclinical | Coronary Artery Disease | UNKNOWN | NCT05593120 |
| CT-FFR | Other | Preclinical | Coronary Artery Disease | UNKNOWN | NCT05593120 |
| Routine care | Other | Preclinical | Coronary Artery Disease | UNKNOWN | NCT05593120 |
| CT-FFR | Other | Preclinical | Coronary Artery Disease | UNKNOWN | NCT05593120 |
| No Intervention Provided | Other | Preclinical | Autism Spectrum Disorder | COMPLETED | NCT03971578 |
| No Intervention Provided | Other | Preclinical | Autism Spectrum Disorder | COMPLETED | NCT03971578 |
| Retinal Implant System (IRIS) | Other | Approved | Retinitis Pigmentosa | UNKNOWN | NCT00427180 |
| Retinal Implant System (IRIS) | Other | Approved | Retinitis Pigmentosa | UNKNOWN | NCT00427180 |
| mSMART smartphone application | Other | Preclinical | Cigarette Smoking | COMPLETED | NCT02072005 |
| mSMART smartphone application | Other | Preclinical | Cigarette Smoking | COMPLETED | NCT02072005 |
| PrEP Smart | Other | Phase PHASE1 | At Risk for HIV | COMPLETED | NCT02895893 |
| PrEP Smart | Other | Phase PHASE1 | At Risk for HIV | COMPLETED | NCT02895893 |
| mSMART | Other | Approved | Nicotine Dependence | UNKNOWN | NCT02635919 |
| mSMART | Other | Approved | Nicotine Dependence | UNKNOWN | NCT02635919 |
| Chantix | Other | Phase PHASE1 | Nicotine Dependence | WITHDRAWN | NCT03069768 |
| mSMART | Other | Phase PHASE1 | Nicotine Dependence | WITHDRAWN | NCT03069768 |
| Chantix | Other | Phase PHASE1 | Nicotine Dependence | WITHDRAWN | NCT03069768 |
| mSMART | Other | Phase PHASE1 | Nicotine Dependence | WITHDRAWN | NCT03069768 |
| PrEP Smart app | Other | Approved | At Risk for HIV | COMPLETED | NCT03080597 |
| PrEP Smart app | Other | Approved | At Risk for HIV | COMPLETED | NCT03080597 |
| prescription drug-abuse education smartphone application | Drug | Approved | Prescription Drug Abuse (Not Dependent) | COMPLETED | NCT03165175 |
| prescription drug-abuse education smartphone application | Drug | Approved | Prescription Drug Abuse (Not Dependent) | COMPLETED | NCT03165175 |
| Dehydration | Other | Approved | Dehydration | COMPLETED | NCT01124903 |
| Dehydration | Other | Approved | Dehydration | COMPLETED | NCT01124903 |
| CA-4F | Other | Approved | Transthyretin Amyloid Cardiomyopathy ("ATTR-CM") | UNKNOWN | NCT05210010 |
| Ultrasound scanning | Other | Preclinical | Ultrasound Imaging of Anatomical Structures | COMPLETED | NCT04918693 |
| Ultrasound scanning | Other | Preclinical | Ultrasound Imaging of Anatomical Structures | COMPLETED | NCT04918693 |
| Ultrasound scans | Other | Preclinical | Ultrasound Imaging of Anatomical Structures | COMPLETED | NCT04906018 |
| Ultrasound scans | Other | Preclinical | Ultrasound Imaging of Anatomical Structures | COMPLETED | NCT04906018 |
| Hyperspectral Imaging | Other | Approved | Lung Neoplasm | NOT_YET_RECRUITING | NCT05676788 |
| Hyperspectral Imaging | Other | Approved | Lung Neoplasm | NOT_YET_RECRUITING | NCT05676788 |
| Ultrasound Scanning - 2 months later | Other | Preclinical | Ultrasound Imaging of Anatomical Structures | COMPLETED | NCT05156099 |
| Ultrasound Scanning | Other | Preclinical | Ultrasound Imaging of Anatomical Structures | COMPLETED | NCT05156099 |
| Ultrasound Scanning - 2 months later | Other | Preclinical | Ultrasound Imaging of Anatomical Structures | COMPLETED | NCT05156099 |
| Ultrasound Scanning | Other | Preclinical | Ultrasound Imaging of Anatomical Structures | COMPLETED | NCT05156099 |
| Clinician | Other | Preclinical | Preoperative Care | UNKNOWN | NCT05945004 |
| ChatGPT-4 | Other | Preclinical | Preoperative Care | UNKNOWN | NCT05945004 |
| Clinician | Other | Preclinical | Preoperative Care | UNKNOWN | NCT05945004 |
| ChatGPT-4 | Other | Preclinical | Preoperative Care | UNKNOWN | NCT05945004 |
| Dexmedetomidine | Other | Approved | Dexmedetomidine | UNKNOWN | NCT05952050 |
| Dexmedetomidine | Other | Approved | Dexmedetomidine | UNKNOWN | NCT05952050 |
| Dexmedetomidine | Other | Approved | Dexmedetomidine | UNKNOWN | NCT05952050 |
| ScanNav Anatomy PNB | Other | Preclinical | Ultrasound Imaging of Anatomical Structures | COMPLETED | NCT05583032 |
| ScanNav Anatomy PNB | Other | Preclinical | Ultrasound Imaging of Anatomical Structures | COMPLETED | NCT05583032 |
| Manual PCI | Other | Approved | Coronary Artery Disease | UNKNOWN | NCT06032572 |
| VRS100 robotic-assisted PCI | Other | Approved | Coronary Artery Disease | UNKNOWN | NCT06032572 |
| Manual PCI | Other | Approved | Coronary Artery Disease | UNKNOWN | NCT06032572 |
| VRS100 robotic-assisted PCI | Other | Approved | Coronary Artery Disease | UNKNOWN | NCT06032572 |
| N/A - non-interventional study | Other | Preclinical | Data Collection | COMPLETED | NCT05992805 |
| N/A - non-interventional study | Other | Preclinical | Data Collection | COMPLETED | NCT05992805 |
| N/A - non-interventional study | Other | Preclinical | Data Collection | COMPLETED | NCT05992805 |
| Ultrasound Scans | Other | Preclinical | Ultrasound | COMPLETED | NCT05963243 |
| Ultrasound Scans | Other | Preclinical | Ultrasound | COMPLETED | NCT05963243 |
| Ultrasound Scans | Other | Preclinical | Ultrasound | COMPLETED | NCT05963243 |
| Ultrasound scans | Other | Preclinical | Ultrasound Recordings | COMPLETED | NCT05963230 |
| Ultrasound scans | Other | Preclinical | Ultrasound Recordings | COMPLETED | NCT05963230 |
| SOUNDSTAR 3D Diagnostic Ultrasound catheter and ACUSON P500 system | Other | Approved | Structural Heart Diseases | NOT_YET_RECRUITING | NCT06344494 |
| Arch EchoTM Intracardiac Ultrasound catheter and ultrasound system | Other | Approved | Structural Heart Diseases | NOT_YET_RECRUITING | NCT06344494 |
| SOUNDSTAR 3D Diagnostic Ultrasound catheter and ACUSON P500 system | Other | Approved | Structural Heart Diseases | NOT_YET_RECRUITING | NCT06344494 |
| Arch EchoTM Intracardiac Ultrasound catheter and ultrasound system | Other | Approved | Structural Heart Diseases | NOT_YET_RECRUITING | NCT06344494 |
| Dental Implant insertion and tooth extraction | Other | Approved | Wound Healing Disorder | COMPLETED | NCT06371430 |
| Dental Implant insertion and tooth extraction | Other | Approved | Wound Healing Disorder | COMPLETED | NCT06371430 |
| Intelligent Fingerprinting Drug Screening System | Drug | Preclinical | Pharmacokinetics | ACTIVE_NOT_RECRUITING | NCT06519045 |
| Medial-Olivocochlear Reflex (MOCR) Strength Measurement | Other | Preclinical | Neonatal Hearing Loss | COMPLETED | NCT04749524 |
| Medial-Olivocochlear Reflex (MOCR) Strength Measurement | Other | Preclinical | Neonatal Hearing Loss | COMPLETED | NCT04749524 |
| Medial-Olivocochlear Reflex (MOCR) Strength Measurement | Other | Preclinical | Neonatal Hearing Loss | COMPLETED | NCT04749524 |
| Fingerprint sweat laboratory analysis | Other | Preclinical | Reagent Kits, Diagnostic | RECRUITING | NCT06618183 |
| Fingerprint sweat drug screen | Drug | Preclinical | Reagent Kits, Diagnostic | RECRUITING | NCT06618183 |
| N/A - non-interventional study | Other | Preclinical | Data Collection | COMPLETED | NCT06550349 |
| N/A - non-interventional study | Other | Preclinical | Data Collection | COMPLETED | NCT06550349 |
| no intervention | Other | Preclinical | Postoperative Delirium | RECRUITING | NCT06423547 |
| no intervention | Other | Preclinical | Postoperative Delirium | RECRUITING | NCT06423547 |
| no intervention | Other | Preclinical | Postoperative Delirium | RECRUITING | NCT06423547 |
| Flat walking training | Other | Approved | Chronic Obstructive Pulmonary Disease | NOT_YET_RECRUITING | NCT06963333 |
| Breathing guided exercise | Other | Approved | Chronic Obstructive Pulmonary Disease | NOT_YET_RECRUITING | NCT06963333 |
| Flat walking training | Other | Approved | Chronic Obstructive Pulmonary Disease | NOT_YET_RECRUITING | NCT06963333 |
| Breathing guided exercise | Other | Approved | Chronic Obstructive Pulmonary Disease | NOT_YET_RECRUITING | NCT06963333 |
| Using Resynk VR on stroke survivors | Other | Approved | Stroke | NOT_YET_RECRUITING | NCT07032155 |
| Resynk VR session | Other | Approved | Stroke | NOT_YET_RECRUITING | NCT07032155 |
| Using Resynk VR on stroke survivors | Other | Approved | Stroke | NOT_YET_RECRUITING | NCT07032155 |
| Resynk VR session | Other | Approved | Stroke | NOT_YET_RECRUITING | NCT07032155 |
| METR-NK cell(metabolic remodeling nature killer cells) | Other | Phase PHASE1 | Ovary Cancer | ACTIVE_NOT_RECRUITING | NCT07096583 |
| METR-NK cell(metabolic remodeling nature killer cells) | Other | Phase PHASE1 | Ovary Cancer | ACTIVE_NOT_RECRUITING | NCT07096583 |
| Using an electrical stimulation device to relieve pain during colonoscopy | Device | Approved | Colonoscopy | RECRUITING | NCT06813703 |
| Using an electrical stimulation device to relieve pain during colonoscopy | Device | Approved | Colonoscopy | RECRUITING | NCT06813703 |
| General Anesthesia (GA) | Other | Approved | Anesthesia Induction | RECRUITING | NCT06857344 |
| AI Controlled General Anesthesia | Other | Approved | Anesthesia Induction | RECRUITING | NCT06857344 |
| General Anesthesia (GA) | Other | Approved | Anesthesia Induction | RECRUITING | NCT06857344 |
| AI Controlled General Anesthesia | Other | Approved | Anesthesia Induction | RECRUITING | NCT06857344 |
| General Anesthesia (GA) | Other | Approved | Anesthesia Induction | RECRUITING | NCT06857344 |
| AI Controlled General Anesthesia | Other | Approved | Anesthesia Induction | RECRUITING | NCT06857344 |
| General Anesthesia | Other | Approved | Painless Abortion | NOT_YET_RECRUITING | NCT07132151 |
| AI Controlled General Anesthesia | Other | Approved | Painless Abortion | NOT_YET_RECRUITING | NCT07132151 |
| General Anesthesia | Other | Approved | Painless Abortion | NOT_YET_RECRUITING | NCT07132151 |
| AI Controlled General Anesthesia | Other | Approved | Painless Abortion | NOT_YET_RECRUITING | NCT07132151 |
| General Anesthesia | Other | Approved | Painless Abortion | NOT_YET_RECRUITING | NCT07132151 |
| AI Controlled General Anesthesia | Other | Approved | Painless Abortion | NOT_YET_RECRUITING | NCT07132151 |
| Routine doctors analyze the process of chest X-rays | Other | Approved | Tuberculosis (TB) | RECRUITING | NCT06963606 |
| Artificial intelligence-assisted chest X-ray in TB screening | Other | Approved | Tuberculosis (TB) | RECRUITING | NCT06963606 |
| Routine doctors analyze the process of chest X-rays | Other | Approved | Tuberculosis (TB) | RECRUITING | NCT06963606 |
| Artificial intelligence-assisted chest X-ray in TB screening | Other | Approved | Tuberculosis (TB) | RECRUITING | NCT06963606 |
| Dual-task cycling | Other | Approved | Healthy Volunteer | COMPLETED | NCT07050654 |
| Dual-task cycling | Other | Approved | Healthy Volunteer | COMPLETED | NCT07050654 |
| Theravex Bioactive Solutions (Tissue Care Plus and Oral) | Other | Approved | Gingival Recession, Localized | RECRUITING | NCT07430670 |
| Modified Free Gingival Graft (M-FGG) | Other | Approved | Gingival Recession, Localized | RECRUITING | NCT07430670 |
| Theravex Bioactive Solutions (Tissue Care Plus and Oral) | Other | Approved | Gingival Recession, Localized | RECRUITING | NCT07430670 |
| Modified Free Gingival Graft (M-FGG) | Other | Approved | Gingival Recession, Localized | RECRUITING | NCT07430670 |
| Robotic bilateral upper limb rehabilitation training | Other | Approved | Congenital and Acquired Neuromotor Disorders | RECRUITING | NCT07092436 |
| Robotic bilateral upper limb rehabilitation training | Other | Approved | Congenital and Acquired Neuromotor Disorders | RECRUITING | NCT07092436 |
| CA-4F | DEVICE | Approved | Transthyretin Amyloid Cardiomyopathy ("ATTR-CM") | UNKNOWN | NCT05210010 |
| No Intervention Provided | OTHER | Preclinical | Autism Spectrum Disorder | COMPLETED | NCT03971578 |
| Intelligent Fingerprinting Drug Screening System | DEVICE | Preclinical | Pharmacokinetics | ACTIVE_NOT_RECRUITING | NCT06519045 |